ABSTRACT
Swollen glands in the neck in African sleeping sickness is usually considered to be a sign of peripheral trypanosomiasis without cerebral involvement. Experimental evidence of connection between these glands and the ventricles of the brain is reviewed. The evidence suggests that Winterbottom's sign may indicate also a cerebral infection. It also suggests that trypanosomes may enter the brain via the lymphatic system.
Subject(s)
Brain Diseases/pathology , Lymph Nodes/pathology , Trypanosomiasis, African/pathology , Animals , Humans , NeckABSTRACT
ORMEROD and HUSSEIN (1986) have shown that an intracellular stage of Trypanosoma brucei rhodesiense causes the destruction of ependymal cells lining the ventricles of the brain. The ventricular ependymal cells are intimately associated with a plexus of nerves that react specifically with monoclonal antibody raised against serotonin. We have shown that in areas where the ependyma is damaged, the supraependymal plexus also undergoes destruction and that retrograde degeneration of the neuron as far as the dorsal raphe nucleus also occurs. Although the work is as yet unfinished, we suggest that some of the neuro-psychological changes, observed in clinical sleeping sickness, may be the result of this lesion.
Subject(s)
Ependyma/physiopathology , Nerve Degeneration , Neurons/metabolism , Serotonin/metabolism , Trypanosomiasis, African/physiopathology , Animals , Rats , Trypanosoma brucei bruceiABSTRACT
The finding of an intracellular stage of Trypanosoma brucei in ependymal cells of the choroid plexus (Abolarin et al., 1986) and of the lining of the ventricles (Ormerod and Hussein, 1986) has suggested a new technique for screening trypanocidal compounds against the failure of drugs to eliminate "occult" stages of the infection (Raseroka and Ormerod, 1986). A (donor) mouse, infected for 28 days, is dosed with a drug, or combination of drugs, and samples of blood, cerebral cortex, choroid plexus and lining of ventricle are injected into clean (recipient) mice. The response of recipient mice shows whether the part, under examination, of the donor mouse has been cleared of trypanosomes. Suramin clears the blood and cerebral cortex but not sites containing ependymal cells (i. e. choroid plexus and lining of ventricle). Melarsoprol is active in all sites but is not always effective. DFMO clears the ependymal cells but its action elsewhere is difficult to evaluate. Metronidazole (inactive on its own), when given with suramin is active at all sites. Bleomycin was the most effective single compound. Bleomycin, an anti-cancer agent registered for use in man, should receive clinical evaluation for sleeping sickness: there is evidence, however, of incompatibility with DFMO.
Subject(s)
Trypanocidal Agents/pharmacology , Trypanosomiasis, African/drug therapy , Animals , Bleomycin/pharmacology , Drug Evaluation, Preclinical/methods , Eflornithine/pharmacology , Melarsoprol/pharmacology , Metronidazole/pharmacology , Mice , Suramin/pharmacology , Trypanosoma brucei bruceiABSTRACT
The fine structure of the normal choroid plexus of rats and mice and of those infected with Trypanosoma brucei was examined by transmission and scanning electron microscopy: extracellular trypomastigotes in the perivascular stroma predominate but the evidence presented suggests that they are derived both from stages in the blood and from others undergoing division within ependymal cells, a process which results in destruction of a large proportion of ependymal cells in the parts of choroid plexus affected. The choroid plexus maintains its integrity by regeneration of an outer layer of ependymal cells.
Subject(s)
Choroid Plexus/parasitology , Trypanosoma brucei brucei/physiology , Animals , Choroid Plexus/ultrastructure , Ependyma/ultrastructure , Female , Intercellular Junctions/ultrastructure , Male , Mice , Microscopy, Electron , Rats , Rats, Inbred Strains , Trypanosomiasis, African/pathologyABSTRACT
The fine structure of ependymal cells lining the cerebral ventricles of normal mice and of mice infected with Trypanosoma brucei was examined by transmission electron microscopy. Most of the ependymal cells had been stripped from the ventricular surface of the brain in infected animals but some of the remaining ependymal cells contained intracellular trypomastigotes. The same process of stripping had occurred in a single human brain that was included in the series, but intracellular forms were not found. The significance of the intracellular forms and the implication of the stripping of ventricular ependymal cells are discussed in relation to the pathogenesis of sleeping sickness.
Subject(s)
Ependyma/parasitology , Trypanosomiasis, African/pathology , Animals , Basement Membrane/parasitology , Cerebral Ventricles/parasitology , Ependyma/ultrastructure , Humans , Mice , Microscopy, Electron , Trypanosoma brucei brucei/ultrastructureABSTRACT
Three parts of the brain, cerebral cortex, lining of ventricle and choroid plexus, are cleared of trypanosomes to different extents by different drugs. There appear to be several barriers preventing drugs from acting in different parts of the brain, the concept of a single "blood-brain barrier" does not account for the phenomena observed. The protection of trypanosomes from certain drugs by the choroid plexus and ventricular wall supports the concept of an intracellular stage of Trypanosoma brucei in the ependymal cell; this concept is also supported by differences in parasitaemia resulting from the inoculation of ependymal and of other tissues. Alternative therapies for sleeping sickness are suggested, one of which (suramin/metronidazole) is being advanced for trials in man.
Subject(s)
Brain/drug effects , Trypanocidal Agents/therapeutic use , Trypanosomiasis, African/drug therapy , Animals , Cerebral Cortex/parasitology , Cerebral Ventricles/parasitology , Choroid Plexus/parasitology , Drug Therapy, Combination , Mice , Trypanosoma brucei brucei/drug effectsSubject(s)
Glycerol/therapeutic use , Salicylamides/therapeutic use , Suramin/therapeutic use , Trypanocidal Agents/therapeutic use , Trypanosomiasis, African/drug therapy , Animals , Blood-Brain Barrier , Cerebral Cortex/parasitology , Cerebral Ventricles/parasitology , Choroid Plexus/parasitology , Female , Humans , Male , Mice , Trypanosoma brucei brucei/drug effectsABSTRACT
Phagocytosis of Trypanosoma brucei rhodesiense by peritoneal macrophages takes place by seizure of the trypomastigote by either end but usually by the anterior. A lamellar sheath similar to that seen in phagocytosis of the promastigote of Leishmania is observed, but it is smaller and does not proceed to envelop the living parasite. The attached trypomastigote becomes pitted and appears to have been killed and partially destroyed before it is completely engulfed.
Subject(s)
Macrophages/immunology , Phagocytosis , Trypanosoma brucei brucei/immunology , Animals , Ascitic Fluid/cytology , Cells, Cultured , Macrophages/parasitology , Macrophages/ultrastructure , Microscopy, Electron, Scanning , Rats , Trypanosoma brucei brucei/ultrastructureABSTRACT
Electronmicrographs of the choroid plexus from rats infected with Trypanosoma brucei rhodesiense showed that trypomastigotes from the perivascular spaces may penetrate and undergo multiple division in the ependymal cells which locally constitute the blood-brain barrier. Progressive degeneration of the ependymal cell liberates trypomastigotes back into the perivascular space, from which re-entry into the blood may occur. Re-entry to the blood does not take place from any tissues other than the brain and its membranes. These findings suggest that the ependymal cells of the choroid plexus are the site of the cryptic stage of the sleeping-sickness trypanosome.
Subject(s)
Choroid Plexus/parasitology , Trypanosomiasis, African/parasitology , Animals , Choroid Plexus/ultrastructure , Ependyma/parasitology , Ependyma/ultrastructure , Epithelium/parasitology , Epithelium/ultrastructure , Mice , Microscopy, Electron , Rats , Trypanosoma brucei brucei/growth & development , Trypanosoma brucei brucei/ultrastructureSubject(s)
Arteriosclerosis/etiology , Cholesterol/metabolism , Eukaryota/metabolism , Lipid Metabolism , Muscle, Smooth, Vascular/metabolism , Absorption , Animals , Biological Evolution , Dietary Fats/therapeutic use , Entamoeba histolytica/metabolism , Fats, Unsaturated/therapeutic use , Hydrolases/metabolism , Leishmania/metabolism , Lipoproteins, HDL/blood , Lipoproteins, HDL/pharmacology , Malaria/metabolism , Plasmodium/metabolism , Protozoan Infections/diet therapy , Trypanosoma/drug effects , Trypanosoma/metabolism , Trypanosomiasis/metabolismABSTRACT
Vesicle formation and acetylene reduction (nitrogenase activity) were observed when washed hyphae from cultures of Frankia sp. CpI1 were transferred to a nitrogen-free medium containing ethylenediaminetetraacetic acid and succinate. Succinate could be replaced by malate or fumarate, but not other carbon sources. Maximum acetylene reduction and vesicle numbers were observed at a pH of 6.0-6.5, at 25-30 degrees Centigrade, and at atmos pheric Po2 or somewhat less (5-20 kPa). Addition of 1 mM NH4Cl almost completely inhibited vesicle formation and acetylene-reducing activity, but did not immediately inhibit such reducing activity by cultures with preexisting vesicles. Acetylene-reducing activity was never observed in the absence of vesicle formation.